Ardsley Advisory Partners »

Legend Biotech 2 Adr Rep Ord shares owned by Ardsley Advisory Partners

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Ardsley Advisory Partners from 13F filings

Historical chart of Ardsley Advisory Partners investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Ardsley Advisory Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Ardsley Advisory Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $5.7M 85k 67.17
2023-06-30 $11M 160k 69.03
2023-03-31 $8.7M 180k 48.22
2022-06-30 $4.5M 81k 55.00

More positions owned by Ardsley Advisory Partners

Celestica Sub Vtg Shs (CLS)
Bioceres Crop Solutions Corp SHS (BIOX)
Aspen Aerogels (ASPN)
Sunopta (STKL)
Itron (ITRI)
Nortonlifelock (GEN)
Sunrun Call Option (RUN)
Pacira Pharmaceuticals Call Option (PCRX)
Procore Technologies (PCOR)
First Solar (FSLR)
Ftai Aviation SHS (FTAI)
Vistra Energy (VST)
Flex Ord (FLEX)
Amazon (AMZN)
Sentinelone Cl A (S)

View all positions for Ardsley Advisory Partners

Top funds holding Legend Biotech 2 Adr Rep Ord

T. Rowe Price Associates
RA Capital Management
Hillhouse Capital Advisors
Wellington Management Company
Massachusetts Financial Services
Paradigm Biocapital Advisors
Henderson Group
Westfield Capital Management Company
Holocene Advisors
Federated Investors
Alliancebernstein
TimesSquare Capital Management
Arrowpoint Asset Management
Matthews International Capital Management
Avidity Partners Management

View all funds holding Legend Biotech 2 Adr Rep Ord